Legg-Calve-Perthes Disease Market Research Report – Forecast to 2027

Global Legg-Calve-Perthes Disease Treatment Market: Type (Surgical and Non-Surgical Methods), Application (Osteoarthritis, Hip Dislocation, Hip Fracture), Age Group (4-6, 6-11 and 12-19 years), End-User (Hospitals and Clinics)–Global Forecast Till 2027

ID: MRFR/MED/4884-HCR | | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global legg-calve-Perthes disease treatment market is expected to register a significant growth during the forecast period (2018–2023).


Legg-calve-perthes is a disease which occurs when the blood supply to the femoral head (upper end of the thigh bone) which fits in the hip socket temporarily stops to flow. As an outcome, the femoral head is no longer round and does not move smoothly in the hip socket, resulting in hip pain and constrained leg movements.


Legg-calve-perthes disease (LCPD) generally occurs in children of age 4 to 10 years. Individuals suffering from the disease go on developing a painful joint disorder called as osteoarthritis in the hips at an early age. Individuals suffering from the legg-calve-Perthes disease are often short compared to healthy individuals due to bone anomalies.


Major factors such as rising frequency rate in Perthes disease and increasing awareness about the Perthes disease boosts the market rate exponentially. Furthermore, the advancement of technology such as point-of-care drug delivery systems and focus on delivering good quality of life are some of the factors contributing to the growth of the market. Not identifying and treating the Perthes disease at initial stages are major restrains for the growth of the market.


Segmentation


The global legg-calve-Perthes disease treatment market has been segmented on the basis of type, application, age group, and end-user.


On the basis of type, the market has been classified as non-surgical and surgical methods. The non-surgical method is segmented into anti-inflammatory medications, casting and bracing, crutches, and others. casting and bracing is further segmented into Newington brace, Toronto orthosis, Scottish rite orthosis,  broomstick plasters, and Birmingham orthosis. The others segment is further segmented into conventional calipers, Snyder slings, slings with crutches, and traction. The surgical method is segmented into femoral osteotomy, innominate osteotomy, a combination of femoral osteotomy, and innominate osteotomy.


On the basis of application, the market has been classified as hip Fracture, hip dislocation, osteoarthritis, and congenital dysplasia of the hip.


On the basis of age group, the market has been classified as 4 to 6 years, 6 to 11 years, 12 to 19 years, and others.


On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgical centers, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European legg-calve-Perthes disease treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The legg-calve-Perthes disease treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The legg-calve-Perthes disease treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Legg-Calve-Perthes Disease Treatment Share, by Region, 2017 (%)


 


Source: MRFR Analysis


In the legg-calve-Perthes disease treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and also due to the rise in frequency of osteoarthritis.


The European market is expected to hold the second largest market share. The market growth in this region can be attributed to government funding and support from the healthcare sector coupled with increasing research and development.


The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.


The market in the Middle East and Africa is expected to account for the smallest share of the global legg-calve-Perthes disease treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global legg-calve-Perthes disease treatment market are BASF, Albemarle, Sunline, IOLCP, Shandong Xinhua Pharmaceutical Co. Ltd, Dr. Reddy's, DePuy Synthes, Prime Medical, Zimmer, Biomet Holdings, Inc., 3M Healthcare, Össur Hf, DJO, and  Stryker Corporation.


Global Legg-Calve-Perthes Disease Treatment Market, by Type



  • Non-Surgical Methods

  • Anti-Inflammatory Medications

  • Ibuprofen

  • Casting and Bracing

  • Newington Brace

  • Toronto Orthosis

  • Scottish Rite Orthosis

  • Broomstick Plasters

  • Birmingham Orthosis

  • Crutches

  • Others

  • Conventional calipers

  • Snyder slings

  • Slings with crutches

  • Traction

  • Surgical Methods

  • Femoral osteotomy

  • Innominate osteotomy

  • Combination of femoral osteotomy and Innominate osteotomy


Global Legg-Calve-Perthes Disease Treatment Market, by Application



  • Hip fracture

  • Hip dislocation

  • Osteoarthritis

  • Congenital dysplasia of the hip


Global Legg-Calve-Perthes Disease Treatment Market, by Age Group



  • Age 4-6 years

  • Age 6–11 years

  • Age 12–19

  • Others


Global Legg-Calve-Perthes Disease Treatment Market, by End-Users



  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Others


Global Legg-Calve-Perthes Disease Treatment Implants Market, by Region



  • Americas

  • North America

  • US

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Advanced Surgical Trainees

  • Governmental Agency

  • Educational Organizations

  • Medical Device Manufacturers

  • Research Institutes and Academic Centers

  • Market Research and Consulting



Frequently Asked Questions (FAQ) :


Lack of awareness can hold back Legg-Calve-Perthes Disease Market growth.

Legg-calve-perthes disease market report has ambulatory surgical centers, clinics, hospitals, and others.

The segments are osteoarthritis, hip dislocation, hip fracture, and congenital dysplasia of the hip in the legg-calve-perthes disease market report.

Legg-calve-perthes disease market report has North America has in charge.

Major players involved in legg-calve-perthes disease market are Albemarle, Sunline, BASF, Shandong Xinhua Pharmaceutical Co. Ltd, IOLCP, DJO, DePuy Synthes, Dr. Reddy's, Zimmer, Biomet Holdings, Inc., Prime Medical, Össur Hf, 3M Healthcare, and Stryker Corporation.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

Chapter 6. Global Legg-Calve-Perthes Disease Treatment Market, by Type

6.1 Introduction

6.2 Non-surgical

6.2.1 Anti-inflammatory medications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Casting and Bracing

6.2.2.1 Newington brace

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2.2Toronto orthosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2.3 Scottish rite orthosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2.4 Broomstick plasters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2.5 The Birmingham orthosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3 Crutches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4 Others

6.2.4.1Conventional calipers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4.2 Snyder slings

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4.3 Slings with crutches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4.4 Traction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Surgical

6.2.1 Femoral osteotomy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Innominate osteotomy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3 Combination of femoral osteotomy and Innominate osteotomy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Legg-Calve-Perthes Disease Treatment Market, by Application

7.1 Introduction

7.2 Hip fracture

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Hip dislocation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Osteoarthritis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Congenital dysplasia of the hip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Legg-Calve-Perthes Disease Treatment Market, by Age groups

8.1 Introduction

8.2 Age 4-6 years

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Age 6-11 years

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Age 12-19 years

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Legg-Calve-Perthes Disease Treatment Market, by End-Users

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Legg-Calve-Perthes Disease Treatment Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 BASF

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Albemarle

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financials Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Sunline

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financials Overview

12.3.4 Key Developments

12.3.5 SWOT Analysis

12.4 IOLCP

12.4.1 Company Overview

12.4.2 Type Overview

12.4.3 Financials Overview

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.5 Shandong Xinhua Pharmaceutical Co.Ltd

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financials Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Dr.Reddy's

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financials Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 DePuy Synthes

12.7.1 Company Overview

12.7.2 Type Overview

12.7.3 Financials Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Prime Medical

12.8.1 Company Overview

12.8.2 Type Overview

12.8.3 Financials Overview

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Zimmer

12.9.1 Company Overview

12.9.2 Type Overview

12.9.3 Financials Overview

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Biomet Holdings, Inc.

12.10.1 Company Overview

12.10.2 Type Overview

12.10.3 Financials Overview

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 3M Healthcare

12.11.1 Company Overview

12.11.2 Type Overview

12.11.3 Financials Overview

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Össur Hf

12.12.1 Company Overview

12.12.2 Type Overview

12.12.3 Financials Overview

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 DJO Global

12.13.1 Company Overview

12.13.2 Type Overview

12.13.3 Financials Overview

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 Stryker Corporation

12.14.1 Company Overview

12.14.2 Type Overview

12.14.3 Financials Overview

12.10.4 Key Developments

12.14.5 SWOT Analysis

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Legg-Calve-Perthes Disease Treatment Market Synopsis, 2020-2027

Table 2 Global Legg-Calve-Perthes Disease Treatment Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Legg-Calve-Perthes Disease Treatment Market, by Region, 2020-2027 (USD Million)

Table 4 Global Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 5 Global Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 6 Global Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 7 Global Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 8 North America: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 9 North America: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 10 North America: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 11 Global Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 12 US: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 13 US: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 14 US: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 15 US: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 16 Canada: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 17 Canada: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 18 Canada: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 19 Canada: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 20 South America: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 21 South America: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 22 South America: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 23 South America: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 24 Europe: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 25 Europe: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 26 Europe: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 27 Europe: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 28 Western Europe: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 29 Western Europe: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 30 Western Europe: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 31 Western Europe: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 32 Eastern Europe: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 33 Eastern Europe: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 34 Eastern Europe: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 35 Eastern Europe: Legg-Calve-Perthes Disease Treatment Market by End Users, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 38 Asia-Pacific: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 39 Asia-Pacific: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Legg-Calve-Perthes Disease Treatment Market, by Type, 2020-2027 (USD Million)

Table 41 Middle East & Africa: Legg-Calve-Perthes Disease Treatment Market, by Application, 2020-2027 (USD Million)

Table 42 Middle East & Africa: Legg-Calve-Perthes Disease Treatment Market, by Age group, 2020-2027 (USD Million)

Table 43 Middle East & Africa: Legg-Calve-Perthes Disease Treatment Market, by End Users, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Legg-Calve-Perthes Disease Treatment Market

Figure 3 Segmentation Market Dynamics for Global Legg-Calve-Perthes Disease Treatment Market

Figure 4 Global Legg-Calve-Perthes Disease Treatment Market Share, by Type, 2020

Figure 5 Global Legg-Calve-Perthes Disease Treatment Market Share, by Application, 2020

Figure 6 Global Legg-Calve-Perthes Disease Treatment Market Share, by Age Group, 2020

Figure 7 Global Legg-Calve-Perthes Disease Treatment Market Share, by End-Users, 2020

Figure 8 Global Legg-Calve-Perthes Disease Treatment Market Share, by Region, 2020

Figure 9 North America: Legg-Calve-Perthes Disease Treatment Market Share, by Country, 2020

Figure 10 Europe: Legg-Calve-Perthes Disease Treatment Market Share, by Country, 2020

Figure 11 Asia-Pacific: Legg-Calve-Perthes Disease Treatment Market Share, by Country, 2020

Figure 12 Middle East & Africa: Legg-Calve-Perthes Disease Treatment Market Share, by Country, 2020

Figure 13 Global Legg-Calve-Perthes Disease Treatment Market: Company Share Analysis, 2020 (%)

Figure 14 BASF: Key Financials

Figure 15 BASF Segmental Revenue

Figure 16 BASF: Geographical Revenue

Figure 17 Albemarle: Key Financials

Figure 18 Albemarle: Segmental Revenue

Figure 19 Albemarle: Geographical Revenue

Figure 20 Sunline: Key Financials

Figure 21 Sunline: Segmental Revenue

Figure 22 Sunline: Geographical Revenue

Figure 23 IOLCP: Key Financials

Figure 24 IOLCP: Segmental Revenue

Figure 25 IOLCP: Geographical Revenue

Figure 26 Shandong Xinhua Pharmaceutical Co.,Ltd: Key Financials

Figure 27 Shandong Xinhua Pharmaceutical Co.,Ltd: Segmental Revenue

Figure 28 Shandong Xinhua Pharmaceutical Co.,Ltd: Geographical Revenue

Figure 29 Dr.Reddy's: Key Financials

Figure 30 Dr.Reddy's: Segmental Revenue

Figure 31 Dr.Reddy's : Geographical Revenue

Figure 32 DePuy Synthes.: Key Financials

Figure 33 DePuy Synthes.: Segmental Revenue

Figure 34 DePuy Synthes.: Geographical Revenue

Figure 35 Prime Medical: Key Financials

Figure 36 Prime Medical: Segmental Revenue

Figure 37 Prime Medical: Geographical Revenue

Figure 38 Zimmer: Key Financials

Figure 39 Zimmer: Segmental Revenue

Figure 40 Zimmer: Geographical Revenue

Figure 41 Biomet Holdings, Inc.: Key Financials

Figure 42 Biomet Holdings, Inc.: Segmental Revenue

Figure 43 Biomet Holdings, Inc.: Geographical Revenue

Figure 44 3M Healthcare: Key Financials

Figure 45 3M Healthcare: Segmental Revenue

Figure 46 3M Healthcare: Geographical Revenue

Figure 47 Össur Hf: Key Financials

Figure 48 Össur Hf: Segmental Revenue

Figure 49 Össur Hf: Geographical Revenue

Figure 50 DJO Global: Key Financials

Figure 51 DJO Global: Segmental Revenue

Figure 52 DJO Global: Geographical Revenue

Figure 53 Stryker Corporation: Key Financials

Figure 54 Stryker Corporation: Segmental Revenue

Figure 55 Stryker Corporation: Geographical Revenue